Cubist Systematic Strategies’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-26,502
| Closed | -$515K | – | 2228 |
|
|
2018
Q1 | $515K | Sell |
26,502
-8,231
| -24% | -$162K | 0.03% | 781 |
|
|
2017
Q4 | $578K | Sell |
34,733
-3,309
| -9% | -$60.7K | 0.03% | 806 |
|
|
2017
Q3 | $772K | Buy |
38,042
+33,507
| +739% | +$641K | 0.04% | 556 |
|
|
2017
Q2 | $73K | Buy |
+4,535
| New | +$67K | ﹤0.01% | 1498 |
|
|
2017
Q1 | – | Sell |
-12,000
| Closed | -$159K | – | 2006 |
|
|
2016
Q4 | $159K | Sell |
12,000
-6,311
| -34% | -$108K | 0.01% | 1353 |
|
|
2016
Q3 | $434K | Sell |
18,311
-7,303
| -29% | -$196K | 0.03% | 776 |
|
|
2016
Q2 | $738K | Buy |
+25,614
| New | +$835K | 0.04% | 580 |
|
|
2016
Q1 | – | Sell |
-30,694
| Closed | -$1.31M | – | 1966 |
|
|
2015
Q4 | $1.31M | Sell |
30,694
-61,812
| -67% | -$2.47M | 0.08% | 358 |
|
|
2015
Q3 | $3.26M | Buy |
92,506
+59,092
| +177% | +$2.66M | 0.16% | 113 |
|
|
2015
Q2 | $1.53M | Buy |
33,414
+18,599
| +126% | +$883K | 0.08% | 367 |
|
|
2015
Q1 | $694K | Buy |
14,815
+6,615
| +81% | +$263K | 0.03% | 750 |
|
|
2014
Q4 | $260K | Buy |
+8,200
| New | +$240K | 0.01% | 1329 |
|
|
2014
Q3 | – | Sell |
-6,821
| Closed | -$205K | – | 1961 |
|
|
2014
Q2 | $205K | Buy |
+6,821
| New | +$184K | 0.01% | 1165 |
|
Cubist Systematic Strategies's IPXL Position: Q2 2018 in Review
Cubist Systematic Strategies sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 26,502 shares — an estimated $515K sold.
Cubist Systematic Strategies first reported a position in IPXL in Q2 2014 and held it in 13 quarters. The position peaked at $3.26M in Q3 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Cubist Systematic Strategies reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Cubist Systematic Strategies sold 26,502 Impax Laboratories, Inc. shares in Q2 2018, an estimated $515K.
- Cubist Systematic Strategies first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 13 quarters.
- Cubist Systematic Strategies's Impax Laboratories, Inc. position peaked at $3.26M in Q3 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Cubist Systematic Strategies's 13F filing for Q2 2018, filed 14 Aug 2018.